Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

MEDLAB TECHNOLOGIES LLC

NPI: 1649928136 · PARK RIDGE, IL 60068 · Clinical Medical Laboratory · NPI assigned 03/14/2022

$87K
Total Medicaid Paid
2,785
Total Claims
1,629
Beneficiaries
5
Codes Billed
2022-07
First Month
2023-05
Last Month

Provider Details

Authorized OfficialAHMED, MOHAMMED (PRESIDENT)
NPI Enumeration Date03/14/2022

Related Entities

Other providers sharing the same authorized official: AHMED, MOHAMMED

ProviderCityStateTotal Paid
MERCIFUL HEALTHCARE SERVICES LLC COLUMBUS OH $9.70M
HOWARD COUNTY GENERAL HOSPITAL, INC, COLUMBIA MD $4.47M
MOHAMMED I AHMED MD INC DUBLIN OH $1.20M
INSTACARE PLLC MORRISTOWN TN $1.09M
ANTIOCH MEDICAL AND HOSPITAL SUPPLY, INC. ANTIOCH CA $437K
CENTER FOR CARDIOVASCULAR CARE A MEDICAL CORPORATION SAN JOSE CA $406K
ARTHRITIS AND RHEUMATISM CENTER INC TOLEDO OH $332K
KIDNEY CENTER PLLC MORRISTOWN TN $191K
GREENVILLE NEURO DIAGNOSTIC CENTER, P.C. GREENVILLE MS $138K
Q DAY WALK IN CLINIC AND SPA, LLC PLANO TX $41K
MERCY MEDICAL TRANSPORTATION LLC COLUMBUS OH $20K
CRITICAL CARE NURSES LLC LAS VEGAS NV $0.00
FAMILY CARE HOME HEALTH & HOSPICE, LLC LAS VEGAS NV $0.00

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2022 1,759 $72K
2023 1,026 $15K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 663 295 $49K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 644 295 $16K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 663 295 $15K
87811 143 83 $6K
K1034 Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count 672 661 $432.96